Company Presentation

Aurealis Therapeutics is a Swiss-Nordic clinical stage Cell & Gene Therapy Company. Our multi-therapy platform is based on safe lactic acid bacteria, genetically modified to produce multiple therapeutic proteins in the body: cytokines, growth factors, antibody fragments. We address multi-factorial diseases with large unmet medical needs: Chronic Wounds – Diabetic Foot Ulcers, Venous Ulcers – deadly Cancers – Ovarian Cancer, Peritoneal Carcinomatosis – Inflammation.